Abstract
Cytokines can be marked out as a new separate regulatory system which, along with nervous and endocrine systems, helps to maintain homeostasis, and these three systems are tightly interconnected and interdependent. Cytokines are the most universal regulatory system, because they can possess both distant biological action after secretion by cell-producer (locally and systemically), and action by intercellular contact as membrane-bound biologically active form. Cytokines include interferons, interleukins, growth and colony-stimulating factors, chemokines, mediators from tumor necrosis factor group, transforming growth factors and some other molecules. Cytokines are not primary mediators of pathology. However cytokines can participate in immunopathologic processes formation and function as diagnostic markers in some diseases. On the other hand the promising perspective of cytokine clinical usage for treatment of widespread diseases, including infectious and cancer, always was the driving force for cytokine study.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aarvak T, Chabaud M, Miossec P, Natvig JB (1999) IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 162:1246–1251
Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3(9):745–756
Aggarwal BB, Natarajan K (1996) Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 7:93–124
Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA et al (1985) Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem 260:2345–2354
Agnello D, Lankford CSR, Bream J et al (2003) Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 23(3):147–161
Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101(10):3765–3777
Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, Luz A, Turetskaya RL et al (1997) Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci USA 94:9302–9307
Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787–820
Almeida A, Legrand N, Papiernik M et al (2002) Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169:4850–4860
Antonysamy MA, Thomson AW (1999) FLT3 ligand (FL) and its influence on immune reactivity. Cytokine 12:87–100
Appasamy PM (1992) IL 7-induced T cell receptor-gamma gene expression by pre-T cells in murine fetal liver cultures. J Immunol 149:1649–1656
Arend WP (1993) Interleukin-1 receptor antagonist. Adv Immunol 54:167–227
Arend WP (2003) The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13(4–5):323–340
Asadullah K, Sabat R, Friedrich M et al (2004) Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy 3(2):185–192
Aspinall R, Henson S, Pido-Lopez J, Ngom PT (2004) Interleukin-7: an interleukin for rejuvenating the immune system. Ann NY Acad Sci 1019:116–122
Bach EA, Aguet M, Schreiber RD (1997) The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15:563–591
Bartlett NW, Buttigieg K, Kotenko SV, Smith GL (2005) Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J General Virol 86:1589–1596
Bazan JF (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87(18):6934–6938
Beadling C, Slifka MK (2006) Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp 54:15–24
Beebe AM, Cua DJ, de Waal Malefyt R (2003) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13(4–5):403–412
Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229(4716):869–871
Bhatia M, Davenport V, Cairo MS (2007) The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. Leuk Lymphoma 48(1):9–15
Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V et al (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6:79–88
Bodmer JL, Schneider P, Tschopp J (2002) The molecular architecture of the TNF superfamily. Trends Biochem Sci 27:19–26
Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174:1549–1555
Bonder CS, Finlay-Jones JJ, Hart PH (1999) Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain. Immunology 96:529–536
Bowcock AM, Kidd JR, Lathrop GM, Daneshvar L, May LT et al (1988) The human interferon-beta 2/hepatocyte stimulating factor/interleukin-6 gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3:8–16
Bowie MB, Kent DG, Copley MR, Eaves CJ (2007) Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells. Blood 109(11):5043–5048
Brasel K, Escobar S, Anderberg R, de Vries P, Gruss H-J, Lyman SD (1995) Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212–1218
Brombacher F, Kastelein RA, Alber G (2003) Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 24:207–212
Brown MA, Hural J (1997) Functions of IL-4 and control of its expression. Crit Rev Immunol 17:1–32
Budagian V, Bulanova E, Orinska Z et al (2004) Reverse signaling through membrane-bound interleukin-15. J Biol Chem 279:42192–42201
Carswell EA, Old LJ, Fiore N, Schwartz MK (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666–3670
Chatila TA (2004) Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med 10(10):493–499
Chinnaiyan AM, O’Rourke K, Yu GL, Lyons RH, Garg M et al (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990–992
Cohen S, Bigazzi PE, Yoshida T (1974) Similarities of T cell function in cell-mediated immunity and antibody production. Cell Immunol 12:150–159
Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T cell function. Nature 450:566–569
Colobran R, Pujol-Borrell R, Armengol MP, Juan M (2007) The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity. Clin Exp Immunol 148:208–217
Cooper M, Bush J, Fehniger T et al (2002) In vivo evidence for a dependence on interleukin-15 for natural killer cell survival. Blood 100:3633–3638
Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9(4):271–285
Curti A, Tafuri A, Ricciardi MR et al (2002) Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1). Haematologica 87(4):373–380
Cytokine: more than a new word, a new concept proposed by Stanley Cohen thirty years ago (2004) Cytokine 28:242–247
de Vries JE, Zurawski G (1995) Immunoregulatory properties of IL-13: its potential role in atopic disease. Int Arch Allergy Immunol 106(3):175–179
Debets R, Savelkoul HF (1994) Cytokine antagonists and their potential therapeutic use. Immunol Today 15(10):455–458
Dessein A, Kouriba B, Eboumbou C et al (2005) Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis. Immunol Rev 201:180–190
Dinarello C (1996) Biological basis for interleukin-1 in disease. Blood 87:2095–2147
Dinarello CA (1998) Interleukin-1 beta, interleukin-18 and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 856:1–11
Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550
Dinarello CA, Wolff SM (1982) Molecular basis of fever in humans. Am J Med 72(5):799–819
Dinarello C, Arend W, Sims J, Smith D, Blumberg H et al (2010) IL-1 family nomenclature. Nat Immunol 11(11):973
Dittel BN, LeBien TW (1995) The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J Immunol 154:58–67
Dong C (2008) Th17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8(5):337–348
Dumonde DC (1986) Work of the Lymphokine Standardization Subcommittee of the International Union of Immunological Societies. Lymphokine Res 5(Suppl 1):S1–S5
Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT (1969) “Lymphokines”: non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 224(5214):38–42
Dumoutier L, Renauld J (2002) Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur Cytokine Netw 13:5–15
Eskdale J, Kube D, Tesch H, Gallagher G (1997) Mapping of the human IL10 gene and further characterization of the 5 flanking sequence. Immunogenetics 46:120–128
Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ et al (2002) IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9 and IL-13. Immunity 17:7–17
Fan X, Sibalic V, Niederer E, Wüthrich RP (1996) The proinflammatory cytokine interleukin-12 occurs as a cell membrane-bound form on macrophages. Biochem Biophys Res Commun 225(3):1063–1067
Fernandez E, Lolis E (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42:469–499
Feuerer M, Hill JA, Mathis D, Benoist C (2009) Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10(7):689–695
Frankenstein Z, Alon U, Cohen IR (2006) The immune-body cytokine network defines a social architecture of cell interactions. Biol Direct 1:32. doi:10.1186/1745–6150–1–32
Gadina M, Hilton D, Johnston JA, Morinobu A, Lighvani A et al (2001) Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol 13(3):363–373
Gaffen SL, Liu KD (2004) Overview of interleukin-2 function, production and clinical applications. Cytokine 28(3):109–123
Geissler EN, Liao M, Brook JD, Martin FH, Zsebo KM et al (1991) Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somat Cell Mol Genet 17(2):207–214
Glauser MP (1997) Cytokines in severe infections: from pathophysiology to clinical applications. Eur Cytokine Netw 8(3):317–318
Gonda TJ, D’Andrea RJ (1997) Activating mutations in cytokine receptors: implications for receptor function and role in disease. Blood 89(2):355–369
Goriely S, Neurath M, Goldman M (2008) How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 8:81–86
Gray PW, Goeddel DV (1982) Structure of the human immune interferon gene. Nature 298(5877):859–863
Gresser I (2007) Interferon: an unfolding tale. J Interferon Cytokine Res 27(6):447–452
Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357
Hamza T, Barnett JB, Li B (2010) Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci 11:789–806
Hardy MP, Owczarek CM, Jermiin LS, Ejdebäck M, Hertzog PJ (2004) Characterization of the type I interferon locus and identification of novel genes. Genomics 84:331–345
Harrington LE, Hatton RD, Mangan PR et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol 6(11):1123–1132
Hehlgans T, Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115(1):1–20
Henney CS, Gaffney J, Bloom BR (1974) On the relation of products of activated lymphocytes to cell-mediated cytolysis. J Exp Med 140(3):837–852
Huising MO, Stet RJ, Savelkoul HF, Verburg-van Kemenade BM (2004) The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish. Dev Comp Immunol 28(5):395–413
Huising MO, Kruiswijk CP, Flik G (2006) Phylogeny and evolution of class-I helical cytokines. J Endocrinol 189:1–25
Ihle JN (1995) Cytokine receptor signalling. Nature 377(6550):591–594
Irwin MR (2008) Human psychoneuroimmunology: 20 years of discovery. Brain Behav Immun 22(2):129–139
Isaacs A, Lindermann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258–267
Ishihara K, Hirano T (2003) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13(4–5):357–368
Izuhara K, Arima K, Yasunaga S (2003) IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Curr Drug Targets Inflamm Allergy 1(3):263–269
Jelkmann W (2007) Erythropoietin after a century of research: younger than ever. Eur J Haematol 78(3):183–205
Jones SA (2005) Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175(6):3463–3468
Kaushansky K (2006) Lineage-specific hematopoietic growth factors. N Engl J Med 354(19):2034–2045
Kishimoto T (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8(Suppl2):2–14
Kishimoto T (2010) IL-6: from its discovery to clinical applications. Int Immunol 22(5):347–352
Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243–1254
Kostyal DA, Beezhold DH, Hall RE (1991) Differentiation-inducing cytokine P48 exists in a membrane-associated form. J Immunol 147(3):893–898
Krejci P, Prochazkova J, Bryja V, Kozubik A, Wilcox WR (2009) Molecular pathology of the fibroblast growth factor family. Hum Mutat 30(9):1245–1255
Kwon B, Kim BS, Cho HR, Park JE, Kwon BS (2003) Involvement of tumor necrosis factor receptor superfamily(TNFRSF) members in the pathogenesis of inflammatory diseases. Exp Mol Med 35(1):8–16
Lata S, Raghava GPS (2008) CytoPred: a server for prediction and classification of cytokines. Prot Engin, Design Select 21(4):279–282
Lebel-Binay S, Berger A, Zinzindohoué F, Cugnenc P-H, Thiounn N et al (2000) Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 11(1):15–26
Lee JS, Campbell HD, Kozak CA, Young IG (1989) The IL-4 and IL-5 genes are closely linked and are part of a cytokine gene cluster on mouse chromosome 11. Somat Cell Mol Genet 15(2):143–152
Leonard WJ, Lin JX (2000) Cytokine receptor signaling pathways. J Allergy Clin Immunol 105(5):877–888
Lingel A, Weiss TM, Niebuhr M, Pan B, Appleton BA et al (2009) Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 17(10):1398–1410
Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275–306
Lodolce JP, Burkett PR, Koka RM et al (2003) Regulation of lymphoid homeostasis by interleukin-15. Cytokine Growth Factor Rev 13(6):429–439
Luster AD (1998) Chemokines – chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445
Malek T, Bayer A (2004) Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4:665–674
Mariathasan S, Newton K, Monack D, Vucic D, French D et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430(6996):213–218
Martinez-Moczygemba M, Huston DP (2003) Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 112(4):653–665
Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165–190
Moroz A, Eppolito C, Li Q et al (2004) IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol 173:900–909
Morris CF, Young IG, Hapel AJ (1990) Molecular and cellular biology of interleukin-3. Immunol Ser 49:177–214
Moseley TA, Haudenschild DR, Rose L, Reddi AH (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14:155–174
Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:123–128
Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of cytokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173
Murdoch C, Finn A (2000) Chemokine receptors and the role in inflammation and infectious disease. J Am Soc Hematol 95(10):3032–3043
Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2:933–944
Musso T, Colosso L, Zucca M et al (1999) Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 93:3531–3539
Naismith JH, Sprang SR (1996) Tumor necrosis factor receptor superfamily. J Inflamm 47(1–2):1–7
Nemunaitis J (1997) A comparative review of colony-stimulating factors. Drugs 54(5):709–729
Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP et al (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37(11):3021–3029
Nishimoto N (2006) Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol 18(3):277–281
Novelli F, Casanova J-L (2004) The role of IL-12, IL-23 and IFN-γ in immunity to viruses. Cytokine Growth Factor Rev 15:367–377
Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola NA (2000) The Online Cytokine Reference Database. http://apresslp.gvpi.net/apcyto/lpext.dll?f=templates&fn=main-h.htm&2.0
O’Sullivan LA, Liongue C, Lewis RS, Stephenson SE, Ward AC (2007) Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol 44(10):2497–2506
Ozaki K, Leonard WJ (2002) Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 277(33):29355–29358
Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ (2000) Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA 97(21):11439–11444
Parrish-Novak J, Dillon S, Nelson A et al (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57–63
Paul WE, Kishimoto T, Melchers E et al (1992) Nomenclature for secreted regulatory proteins of the immune system (interleukins). WHO-IUIS Nomenclature Subcommittee on Interleukin Designation. Clin Exp Immunol 88:367
Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22:929–979
Proulx F, Joyal JS, Mariscalco MM, Leteurtre S, Leclerc F, Lacroix J (2009) The pediatric multiple organ dysfunction syndrome. Ped Crit Care Med 10(1):2–22
Puri RK (1995) Structure and function of interleukin-4 and its receptor. Cancer Treat Res 80:143–185
Ransohoff RM, Liu L, Cardona AE (2007) Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int Rev Neurobiol 82:187–204
Rouveix B (1997) Clinical pharmacology of cytokines. Eur Cytokine Netw 8(3):291–293
Schäfer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A et al (2004) Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood 103:407–412
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479–490
Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163–189
Schultz U, Kaspers B, Staeheli P (2004) The interferon system of non-mammalian vertebrates. Dev Comp Immunol 28:499–508
Schuster B, Kovaleva M, Sun Y, Regenhard P, Matthews V et al (2003) Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF. J Biol Chem (US) 278(11):9528–9535
Schwantner A, Dingley AJ, Ozbek S, Rose-John S, Grötzinger J (2004) Direct determination of the interleukin-6 binding epitope of the interleukin-6 receptor by NMR spectroscopy. J Biol Chem (US) 279(1):571–576
Sen GC (2001) Viruses and interferons. Ann Rev Microbiol 55:255–281
Shortman K, Naik SH (2007) Steady-stat and inflammatory dendritic-cell development. Nat Rev Immunol 7(1):19–30
Simon D, Braathen L, Simon H (2004) Eosinophils and atopic dermatitis. Allergy 59:561–570
Sims J, Nicklin M, Bazan J et al (2001) A new nomenclature for IL-1-family genes. Trends Immunol 22:536–537
Smallwood PM, Munozsanjuan I, Tong P, Macle JP, Hendry SHC et al (1996) Fibroblast growth factor (FGF) homologous factors – new members of the FGF family implicated in nervous-system development. Proc Natl Acad Sci USA 93(18):9850–9857
Smith KA (1988) Interleukin-2: inception, impact, and implications. Science 240(4856):1169–1176
Smith K (2001) Interleukin 2 immunotherapy. In: Austen F, Burakoff S, Rosen F, Strom T (eds) Therapeutic immunology, 2nd edn. Blackwell Science, Malden, MA, pp 240–250
Smith KA (2006) The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs. Med Immunol 5(3):1–5
So T, Lee SW, Croft M (2006) Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol 83(1):1–11
Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19(3):281–286
Taga T, Kishimoto T (1992) Cytokine receptors and signal transduction. FASEB J 6:3387–3396
Tang P, Hung MC, Klostergaard J (1996) Human pro-tumor necrosis factor is a homotrimer. Biochemistry 35(25):8216–8225
Tavernier J, Cornelis S, Devos R, Guisez Y, Plaetinck G, Van der Heyden J (1995) Structure/function analysis of human interleukin 5 and its receptor. Agents Actions Suppl 46:23–34
Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87–113
The Cytokines Web. http://cmbi.bjmu.edu.cn/cmbidata/cgf/CGF_Database/cytweb/targets/index.html
Thomson AW, Lotze MT (2003) The cytokine handbook, 4th edn. Academic, Amsterdam
Throm MJ (2008) A review of the pharmacology and pharmacotherapy of colony-stimulating factors. J Infus Nurs 31(5):295–306
Tieri P, Valensin S, Latora V, Castellani GC, Marchiori M et al (2005) Quantifying the relevance of different mediators in the human immune cell network. Bioinformatics 21:1639–1643
Tominaga A, Takaki S, Hitoshi Y, Takatsu K (1992) Role of the interleukin 5 receptor system in hematopoiesis: molecular basis for overlapping function of cytokines. Bioessays 14(8):527–533
Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J et al (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 177(1):36–39
Tracey K (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117:289–296
Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133–146
Tuck DP, Cerretti DP, Hand A, Guha A, Sorba S, Dainiak N (1994) Human macrophage colony-stimulating factor is expressed at and shed from the cell surface. Blood 84:2182–2188
Uzé G, Schreiber G, Piehler J, Pellegrini S (2007) The receptor of the type I interferon family. Curr Top Microbiol Immunol 316:71–95
Vgontzas AN, Bixler EO, Lin HM et al (2005) IL-6 and its circadian secretion in humans. Neuroimmunomodulation 12(3):131–140
Vilcek J (2003) Novel interferons. Nat Immunol 4:8–9
Vilcek J (2007) My fifty years with interferon. J Interferon Cytokine Res 27(7):535–542
Waldmann TA (2006) The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immun 6(8):595–601
Walz A, Peveri P, Aschauer H et al (1987) Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 149:755–761
Ward PA, Remold HG, David JR (1969) Leukotactic factor produced by sensitized lymphocytes. Science 163(871):1079–1081
Wills-Karp M (2000) The gene encoding interleukin-13: a susceptibility locus for asthma and related traits. Respir Res 1:19–23
Wilson KP, Black JA, Thomson JA et al (1994) Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370:270–273
Yasukawa M, Yakushijin Y, Hasegawa H, Miyake M, Hitsumoto Y et al (1993) Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones. Blood 81:1527–1534
Yoshimura T, Matsuhima K, Tanaka S et al (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defence cytokines. Proc Natl Acad Sci USA 94:9233–9237
Yu J, Gaffen S (2008) Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 13:170–177
Zdanov A, Schalkhini C, Wlodawer A (1996) Crystal-structure of human interleukin-10 at 1.6 angstrom resolution and a model of a complex with its soluble receptor. Prot Sci 5(10):1955–1962
Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE et al (2005) Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med 201:139–148
Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121–127
Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:243
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Simbirtsev, A.S., Kozlov, I.G. (2012). Cytokine System. In: Kamkin, A., Kiseleva, I. (eds) Mechanical Stretch and Cytokines. Mechanosensitivity in Cells and Tissues, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2004-6_1
Download citation
DOI: https://doi.org/10.1007/978-94-007-2004-6_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2003-9
Online ISBN: 978-94-007-2004-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)